25 XP   0   0   10

Euromedis Groupe SA
Buy, Hold or Sell?

Let's analyse Euromedis together

PenkeI guess you are interested in Euromedis Groupe SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Euromedis Groupe SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Euromedis Groupe SA

I send you an email if I find something interesting about Euromedis Groupe SA.

Quick analysis of Euromedis (30 sec.)










What can you expect buying and holding a share of Euromedis? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
44.4%

What is your share worth?

Current worth
€11.67
Expected worth in 1 year
€12.06
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
€0.39
Return On Investment
8.4%

For what price can you sell your share?

Current Price per Share
€4.64
Expected price per share
€4.12 - €5.04
How sure are you?
50%

1. Valuation of Euromedis (5 min.)




Live pricePrice per Share (EOD)

€4.64

Intrinsic Value Per Share

€3.61 - €16.56

Total Value Per Share

€15.29 - €28.24

2. Growth of Euromedis (5 min.)




Is Euromedis growing?

Current yearPrevious yearGrowGrow %
How rich?$37.3m$44.1m-$6.8m-18.2%

How much money is Euromedis making?

Current yearPrevious yearGrowGrow %
Making money-$6.3m$2.4m-$8.7m-137.9%
Net Profit Margin-11.0%2.0%--

How much money comes from the company's main activities?

3. Financial Health of Euromedis (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#181 / 334

Most Revenue
#99 / 334

Most Profit
#234 / 334

Most Efficient
#158 / 334

What can you expect buying and holding a share of Euromedis? (5 min.)

Welcome investor! Euromedis's management wants to use your money to grow the business. In return you get a share of Euromedis.

What can you expect buying and holding a share of Euromedis?

First you should know what it really means to hold a share of Euromedis. And how you can make/lose money.

Speculation

The Price per Share of Euromedis is €4.64. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Euromedis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Euromedis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €11.67. Based on the TTM, the Book Value Change Per Share is €0.10 per quarter. Based on the YOY, the Book Value Change Per Share is €0.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Euromedis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-2.12-45.8%-2.12-45.8%0.6814.6%0.4610.0%0.4910.6%
Usd Book Value Change Per Share0.102.3%0.102.3%0.6614.3%0.5111.0%1.3929.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.051.0%
Usd Total Gains Per Share0.102.3%0.102.3%0.6614.3%0.5111.0%1.4330.9%
Usd Price Per Share5.15-5.15-11.24-8.59-8.14-
Price to Earnings Ratio-2.42--2.42-16.58-1.72--11.21-
Price-to-Total Gains Ratio49.28-49.28-16.99-12.44-8.61-
Price to Book Ratio0.41-0.41-0.91-0.85-0.81-
Price-to-Total Gains Ratio49.28-49.28-16.99-12.44-8.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.965728
Number of shares201
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.100.51
Usd Total Gains Per Share0.100.51
Gains per Quarter (201 shares)21.00102.34
Gains per Year (201 shares)83.99409.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1084740409399
201681580819808
30252242012281217
40336326016371626
50420410020472035
60504494024562444
70588578028662853
80672662032753262
90756746036843671
100840830040944080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%5.04.00.055.6%5.04.00.055.6%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%6.03.00.066.7%6.03.00.066.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%4.00.05.044.4%4.00.05.044.4%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%6.03.00.066.7%6.03.00.066.7%

Fundamentals of Euromedis

About Euromedis Groupe SA

Euromedis Groupe, through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally. It offers sterile or non-sterile medical gloves, dressings and compresses, medical sets, parenteral approach, needles, syringes, infusers, catheters, etc.; and wound drainage products, probes, and a draping range for operating theaters, as well as surgical gloves and protective covers. The company also provides oxygen therapy; incontinence and various hygiene-related products; a range of diagnostics; and a range of home care products. In addition, it distributes and rents vehicles and equipment for the physically handicapped; and provides home infusion and nutrition services under the PARAMAT and the MEDIS SANTE name. The company was founded in 1985 and is based in Mouy, France.

Fundamental data was last updated by Penke on 2024-04-09 12:07:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Euromedis Groupe SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Euromedis earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Euromedis to the Medical Devices industry mean.
  • A Net Profit Margin of -11.0% means that €-0.11 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Euromedis Groupe SA:

  • The MRQ is -11.0%. The company is making a huge loss. -2
  • The TTM is -11.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-11.0%TTM-11.0%0.0%
TTM-11.0%YOY2.0%-13.0%
TTM-11.0%5Y-1.7%-9.3%
5Y-1.7%10Y-0.1%-1.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.0%-12.4%+1.4%
TTM-11.0%-20.4%+9.4%
YOY2.0%-14.8%+16.8%
5Y-1.7%-21.3%+19.6%
10Y-0.1%-25.0%+24.9%
1.1.2. Return on Assets

Shows how efficient Euromedis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Euromedis to the Medical Devices industry mean.
  • -9.9% Return on Assets means that Euromedis generated €-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Euromedis Groupe SA:

  • The MRQ is -9.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.9%TTM-9.9%0.0%
TTM-9.9%YOY3.1%-13.0%
TTM-9.9%5Y0.3%-10.3%
5Y0.3%10Y1.3%-1.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.9%-4.1%-5.8%
TTM-9.9%-4.7%-5.2%
YOY3.1%-4.8%+7.9%
5Y0.3%-4.0%+4.3%
10Y1.3%-5.2%+6.5%
1.1.3. Return on Equity

Shows how efficient Euromedis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Euromedis to the Medical Devices industry mean.
  • -17.2% Return on Equity means Euromedis generated €-0.17 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Euromedis Groupe SA:

  • The MRQ is -17.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.2%TTM-17.2%0.0%
TTM-17.2%YOY5.5%-22.7%
TTM-17.2%5Y0.4%-17.6%
5Y0.4%10Y2.6%-2.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.2%-4.2%-13.0%
TTM-17.2%-5.8%-11.4%
YOY5.5%-5.7%+11.2%
5Y0.4%-6.3%+6.7%
10Y2.6%-7.1%+9.7%

1.2. Operating Efficiency of Euromedis Groupe SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Euromedis is operating .

  • Measures how much profit Euromedis makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Euromedis to the Medical Devices industry mean.
  • An Operating Margin of -10.4% means the company generated €-0.10  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Euromedis Groupe SA:

  • The MRQ is -10.4%. The company is operating very inefficient. -2
  • The TTM is -10.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-10.4%TTM-10.4%0.0%
TTM-10.4%YOY6.4%-16.8%
TTM-10.4%5Y0.7%-11.2%
5Y0.7%10Y1.8%-1.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.4%-24.3%+13.9%
TTM-10.4%-16.4%+6.0%
YOY6.4%-13.7%+20.1%
5Y0.7%-19.9%+20.6%
10Y1.8%-24.5%+26.3%
1.2.2. Operating Ratio

Measures how efficient Euromedis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are €1.10 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Euromedis Groupe SA:

  • The MRQ is 1.104. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.104. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.104TTM1.1040.000
TTM1.104YOY0.967+0.137
TTM1.1045Y1.132-0.028
5Y1.13210Y1.263-0.131
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1041.442-0.338
TTM1.1041.439-0.335
YOY0.9671.431-0.464
5Y1.1321.436-0.304
10Y1.2631.374-0.111

1.3. Liquidity of Euromedis Groupe SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Euromedis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 5.43 means the company has €5.43 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Euromedis Groupe SA:

  • The MRQ is 5.435. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.435. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.435TTM5.4350.000
TTM5.435YOY4.714+0.720
TTM5.4355Y3.046+2.389
5Y3.04610Y2.364+0.682
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4352.726+2.709
TTM5.4352.732+2.703
YOY4.7143.510+1.204
5Y3.0463.617-0.571
10Y2.3643.499-1.135
1.3.2. Quick Ratio

Measures if Euromedis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Euromedis to the Medical Devices industry mean.
  • A Quick Ratio of 3.74 means the company can pay off €3.74 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Euromedis Groupe SA:

  • The MRQ is 3.736. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.736. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.736TTM3.7360.000
TTM3.736YOY3.734+0.002
TTM3.7365Y2.118+1.618
5Y2.11810Y1.487+0.630
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7361.491+2.245
TTM3.7361.633+2.103
YOY3.7342.113+1.621
5Y2.1182.295-0.177
10Y1.4872.255-0.768

1.4. Solvency of Euromedis Groupe SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Euromedis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Euromedis to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.42 means that Euromedis assets are financed with 41.7% credit (debt) and the remaining percentage (100% - 41.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Euromedis Groupe SA:

  • The MRQ is 0.417. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.417. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.417TTM0.4170.000
TTM0.417YOY0.433-0.016
TTM0.4175Y0.543-0.125
5Y0.54310Y0.528+0.015
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4170.389+0.028
TTM0.4170.386+0.031
YOY0.4330.335+0.098
5Y0.5430.442+0.101
10Y0.5280.461+0.067
1.4.2. Debt to Equity Ratio

Measures if Euromedis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Euromedis to the Medical Devices industry mean.
  • A Debt to Equity ratio of 72.0% means that company has €0.72 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Euromedis Groupe SA:

  • The MRQ is 0.720. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.720. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.720TTM0.7200.000
TTM0.720YOY0.768-0.048
TTM0.7205Y1.331-0.611
5Y1.33110Y1.200+0.131
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7200.551+0.169
TTM0.7200.554+0.166
YOY0.7680.479+0.289
5Y1.3310.622+0.709
10Y1.2000.674+0.526

2. Market Valuation of Euromedis Groupe SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Euromedis generates.

  • Above 15 is considered overpriced but always compare Euromedis to the Medical Devices industry mean.
  • A PE ratio of -2.42 means the investor is paying €-2.42 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Euromedis Groupe SA:

  • The EOD is -2.337. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.423. Based on the earnings, the company is expensive. -2
  • The TTM is -2.423. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.337MRQ-2.423+0.086
MRQ-2.423TTM-2.4230.000
TTM-2.423YOY16.582-19.005
TTM-2.4235Y1.715-4.138
5Y1.71510Y-11.212+12.927
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.337-1.077-1.260
MRQ-2.423-1.704-0.719
TTM-2.423-2.081-0.342
YOY16.582-2.978+19.560
5Y1.715-2.379+4.094
10Y-11.212-1.726-9.486
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Euromedis Groupe SA:

  • The EOD is -6.666. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.910. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.910. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.666MRQ-6.910+0.244
MRQ-6.910TTM-6.9100.000
TTM-6.910YOY2.149-9.059
TTM-6.9105Y-6.016-0.894
5Y-6.01610Y15.533-21.549
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-6.666-0.932-5.734
MRQ-6.910-1.578-5.332
TTM-6.910-2.973-3.937
YOY2.149-6.318+8.467
5Y-6.016-5.307-0.709
10Y15.533-5.171+20.704
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Euromedis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.41 means the investor is paying €0.41 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Euromedis Groupe SA:

  • The EOD is 0.398. Based on the equity, the company is cheap. +2
  • The MRQ is 0.412. Based on the equity, the company is cheap. +2
  • The TTM is 0.412. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.398MRQ0.412-0.015
MRQ0.412TTM0.4120.000
TTM0.412YOY0.907-0.495
TTM0.4125Y0.853-0.441
5Y0.85310Y0.815+0.039
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.3981.876-1.478
MRQ0.4122.372-1.960
TTM0.4122.434-2.022
YOY0.9073.217-2.310
5Y0.8533.893-3.040
10Y0.8154.245-3.430
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Euromedis Groupe SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0980.0980%0.618-84%0.476-79%1.297-92%
Book Value Per Share--11.67211.6720%11.575+1%9.445+24%9.366+25%
Current Ratio--5.4355.4350%4.714+15%3.046+78%2.364+130%
Debt To Asset Ratio--0.4170.4170%0.433-4%0.543-23%0.528-21%
Debt To Equity Ratio--0.7200.7200%0.768-6%1.331-46%1.200-40%
Dividend Per Share----0%-0%-0%0.042-100%
Eps---1.985-1.9850%0.633-414%0.432-559%0.459-533%
Free Cash Flow Per Share---0.696-0.6960%4.886-114%1.319-153%0.843-183%
Free Cash Flow To Equity Per Share---1.501-1.5010%4.536-133%1.785-184%0.931-261%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--16.563--------
Intrinsic Value_10Y_min--3.614--------
Intrinsic Value_1Y_max--2.404--------
Intrinsic Value_1Y_min--1.089--------
Intrinsic Value_3Y_max--6.656--------
Intrinsic Value_3Y_min--2.662--------
Intrinsic Value_5Y_max--10.224--------
Intrinsic Value_5Y_min--3.554--------
Market Cap13865804.800-4%14373819.20014373819.2000%37409557.500-62%26751945.128-46%24257592.513-41%
Net Profit Margin---0.110-0.1100%0.020-645%-0.017-84%-0.001-99%
Operating Margin---0.104-0.1040%0.064-264%0.007-1572%0.018-679%
Operating Ratio--1.1041.1040%0.967+14%1.132-2%1.263-13%
Pb Ratio0.398-4%0.4120.4120%0.907-55%0.853-52%0.815-49%
Pe Ratio-2.337+4%-2.423-2.4230%16.582-115%1.715-241%-11.212+363%
Price Per Share4.640-4%4.8104.8100%10.500-54%8.030-40%7.604-37%
Price To Free Cash Flow Ratio-6.666+4%-6.910-6.9100%2.149-422%-6.016-13%15.533-144%
Price To Total Gains Ratio47.537-4%49.27849.2780%16.988+190%12.441+296%8.606+473%
Quick Ratio--3.7363.7360%3.734+0%2.118+76%1.487+151%
Return On Assets---0.099-0.0990%0.031-421%0.003-3317%0.013-852%
Return On Equity---0.172-0.1720%0.055-412%0.004-3949%0.026-760%
Total Gains Per Share--0.0980.0980%0.618-84%0.476-79%1.339-93%
Usd Book Value--37329646.20037329646.2000%44133977.800-15%32955096.680+13%31485640.733+19%
Usd Book Value Change Per Share--0.1040.1040%0.661-84%0.509-79%1.388-92%
Usd Book Value Per Share--12.49212.4920%12.387+1%10.108+24%10.024+25%
Usd Dividend Per Share----0%-0%-0%0.045-100%
Usd Eps---2.125-2.1250%0.678-414%0.463-559%0.491-533%
Usd Free Cash Flow---2226016.000-2226016.0000%18631111.800-112%5256847.871-142%3271853.373-168%
Usd Free Cash Flow Per Share---0.745-0.7450%5.229-114%1.412-153%0.902-183%
Usd Free Cash Flow To Equity Per Share---1.606-1.6060%4.854-133%1.911-184%0.996-261%
Usd Market Cap14839184.297-4%15382861.30815382861.3080%40035708.437-62%28629931.676-46%25960475.508-41%
Usd Price Per Share4.966-4%5.1485.1480%11.237-54%8.594-40%8.138-37%
Usd Profit---6373041.000-6373041.0000%2414371.200-364%2193696.388-391%1905075.149-435%
Usd Revenue--57986646.60057986646.6000%119756450.200-52%109724135.555-47%95537204.197-39%
Usd Total Gains Per Share--0.1040.1040%0.661-84%0.509-79%1.433-93%
 EOD+2 -6MRQTTM+0 -0YOY+11 -225Y+13 -2010Y+12 -23

3.2. Fundamental Score

Let's check the fundamental score of Euromedis Groupe SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.337
Price to Book Ratio (EOD)Between0-10.398
Net Profit Margin (MRQ)Greater than0-0.110
Operating Margin (MRQ)Greater than0-0.104
Quick Ratio (MRQ)Greater than13.736
Current Ratio (MRQ)Greater than15.435
Debt to Asset Ratio (MRQ)Less than10.417
Debt to Equity Ratio (MRQ)Less than10.720
Return on Equity (MRQ)Greater than0.15-0.172
Return on Assets (MRQ)Greater than0.05-0.099
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Euromedis Groupe SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.700
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets59,868
Total Liabilities24,987
Total Stockholder Equity34,700
 As reported
Total Liabilities 24,987
Total Stockholder Equity+ 34,700
Total Assets = 59,868

Assets

Total Assets59,868
Total Current Assets51,874
Long-term Assets7,996
Total Current Assets
Cash And Cash Equivalents 26,801
Short-term Investments 12
Net Receivables 8,846
Inventory 12,591
Other Current Assets 3,636
Total Current Assets  (as reported)51,874
Total Current Assets  (calculated)51,886
+/- 12
Long-term Assets
Property Plant Equipment 4,324
Goodwill 2,540
Intangible Assets 87
Long-term Assets Other 1,045
Long-term Assets  (as reported)7,996
Long-term Assets  (calculated)7,996
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,545
Long-term Liabilities15,442
Total Stockholder Equity34,700
Total Current Liabilities
Short-term Debt 3
Short Long Term Debt 3
Accounts payable 7,309
Other Current Liabilities 2,132
Total Current Liabilities  (as reported)9,545
Total Current Liabilities  (calculated)9,447
+/- 98
Long-term Liabilities
Long term Debt Total 12,785
Capital Lease Obligations Min Short Term Debt-3
Other Liabilities 2,672
Long-term Liabilities  (as reported)15,442
Long-term Liabilities  (calculated)15,454
+/- 12
Total Stockholder Equity
Common Stock6,021
Retained Earnings -5,933
Accumulated Other Comprehensive Income 19,912
Capital Surplus 9,213
Total Stockholder Equity (as reported)34,700
Total Stockholder Equity (calculated)29,213
+/- 5,487
Other
Capital Stock6,021
Cash and Short Term Investments 26,801
Common Stock Shares Outstanding 2,924
Current Deferred Revenue101
Liabilities and Stockholders Equity 59,868
Net Debt -13,963
Net Invested Capital 47,538
Net Working Capital 42,329
Property Plant and Equipment Gross 13,611
Short Long Term Debt Total 12,838



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
54,775
56,549
56,753
57,240
50,356
60,159
92,615
72,722
59,868
59,86872,72292,61560,15950,35657,24056,75356,54954,775
   > Total Current Assets 
34,083
36,244
36,598
37,143
34,826
41,671
83,301
64,411
51,874
51,87464,41183,30141,67134,82637,14336,59836,24434,083
       Cash And Cash Equivalents 
1,581
1,850
1,703
1,007
1,267
5,117
15,735
31,860
26,801
26,80131,86015,7355,1171,2671,0071,7031,8501,581
       Short-term Investments 
0
0
0
0
216
429
40
26
12
1226404292160000
       Net Receivables 
15,415
15,660
15,214
17,756
17,248
16,926
41,853
19,127
8,846
8,84619,12741,85316,92617,24817,75615,21415,66015,415
       Inventory 
13,200
14,082
13,708
17,477
15,687
18,161
25,711
11,760
12,591
12,59111,76025,71118,16115,68717,47713,70814,08213,200
       Other Current Assets 
3,600
4,431
359
3,353
131
1,467
2
1,638
3,636
3,6361,63821,4671313,3533594,4313,600
   > Long-term Assets 
0
0
20,155
20,097
0
18,059
9,314
8,313
7,996
7,9968,3139,31418,059020,09720,15500
       Property Plant Equipment 
7,174
7,101
6,709
6,246
5,772
8,452
4,272
4,398
4,324
4,3244,3984,2728,4525,7726,2466,7097,1017,174
       Goodwill 
1,527
1,527
1,527
1,527
4,656
1,221
3,714
2,627
2,540
2,5402,6273,7141,2214,6561,5271,5271,5271,527
       Long Term Investments 
448
515
627
751
885
0
0
0
0
0000885751627515448
       Intangible Assets 
11,249
10,774
10,787
10,520
3,598
6,852
133
142
87
871421336,8523,59810,52010,78710,77411,249
       Long-term Assets Other 
0
0
20,155
1,223
0
429
1,195
1,146
1,045
1,0451,1461,19542901,22320,15500
> Total Liabilities 
29,197
27,945
27,916
29,443
29,092
42,504
53,687
31,483
24,987
24,98731,48353,68742,50429,09229,44327,91627,94529,197
   > Total Current Liabilities 
24,397
22,786
23,336
24,915
26,020
32,180
34,062
13,663
9,545
9,54513,66334,06232,18026,02024,91523,33622,78624,397
       Short-term Debt 
925
303
4,329
7,777
10,313
14,699
1,297
541
3
35411,29714,69910,3137,7774,329303925
       Short Long Term Debt 
925
303
7,661
5,496
2,799
13,697
1,297
541
3
35411,29713,6972,7995,4967,661303925
       Accounts payable 
12,393
12,105
12,362
12,177
9,475
12,528
20,652
10,504
7,309
7,30910,50420,65212,5289,47512,17712,36212,10512,393
       Other Current Liabilities 
3,484
3,211
3,192
4,961
456
4,819
13
213
2,132
2,132213134,8194564,9613,1923,2113,484
   > Long-term Liabilities 
0
0
4,608
4,528
0
10,324
19,625
17,820
15,442
15,44217,82019,62510,32404,5284,60800
       Long term Debt Total 
0
0
1,768
1,889
1,169
19,960
17,697
15,467
12,785
12,78515,46717,69719,9601,1691,8891,76800
       Capital Lease Obligations 
0
0
985
864
0
3,207
0
0
0
0003,207086498500
       Long-term Liabilities Other 
0
0
0
0
0
0
0
3
2
230000000
> Total Stockholder Equity
25,606
28,641
28,837
27,813
21,264
17,637
38,710
40,995
34,700
34,70040,99538,71017,63721,26427,81328,83728,64125,606
   Common Stock
5,982
5,982
5,982
5,982
5,982
5,982
6,017
6,021
6,021
6,0216,0216,0175,9825,9825,9825,9825,9825,982
   Retained Earnings 
2,553
2,473
13,597
13,171
-6,970
2,640
22,664
2,256
-5,933
-5,9332,25622,6642,640-6,97013,17113,5972,4732,553
   Capital Surplus 
0
0
9,158
9,158
9,158
9,158
9,208
9,213
9,213
9,2139,2139,2089,1589,1589,1589,15800
   Treasury Stock0000-175-104-14100
   Other Stockholders Equity 
8,092
11,226
-63
8,660
13,269
7,990
-13,691
6,743
14,700
14,7006,743-13,6917,99013,2698,660-6311,2268,092



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue54,183
Cost of Revenue-35,437
Gross Profit18,74618,746
 
Operating Income (+$)
Gross Profit18,746
Operating Expense-24,404
Operating Income-5,658-5,658
 
Operating Expense (+$)
Research Development0
Selling General Administrative25,859
Selling And Marketing Expenses0
Operating Expense24,40425,859
 
Net Interest Income (+$)
Interest Income18
Interest Expense-365
Other Finance Cost-219
Net Interest Income-128
 
Pretax Income (+$)
Operating Income-5,658
Net Interest Income-128
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,996-5,320
EBIT - interestExpense = -6,023
-5,996
-5,590
Interest Expense365
Earnings Before Interest and Taxes (EBIT)-5,658-5,631
Earnings Before Interest and Taxes (EBITDA)-4,240
 
After tax Income (+$)
Income Before Tax-5,996
Tax Provision--41
Net Income From Continuing Ops-5,939-5,955
Net Income-5,955
Net Income Applicable To Common Shares-5,933
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses59,841
Total Other Income/Expenses Net-338128
 

Technical Analysis of Euromedis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Euromedis. The general trend of Euromedis is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Euromedis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Euromedis Groupe SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.76 < 4.95 < 5.04.

The bearish price targets are: 4.52 > 4.52 > 4.12.

Tweet this
Euromedis Groupe SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Euromedis Groupe SA. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Euromedis Groupe SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Euromedis Groupe SA.

Euromedis Groupe SA Daily Moving Average Convergence/Divergence (MACD) ChartEuromedis Groupe SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Euromedis Groupe SA. The current adx is .

Euromedis Groupe SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Euromedis Groupe SA.

Euromedis Groupe SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Euromedis Groupe SA.

Euromedis Groupe SA Daily Relative Strength Index (RSI) ChartEuromedis Groupe SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Euromedis Groupe SA.

Euromedis Groupe SA Daily Stochastic Oscillator ChartEuromedis Groupe SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Euromedis Groupe SA.

Euromedis Groupe SA Daily Commodity Channel Index (CCI) ChartEuromedis Groupe SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Euromedis Groupe SA.

Euromedis Groupe SA Daily Chande Momentum Oscillator (CMO) ChartEuromedis Groupe SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Euromedis Groupe SA.

Euromedis Groupe SA Daily Williams %R ChartEuromedis Groupe SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Euromedis Groupe SA.

Euromedis Groupe SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Euromedis Groupe SA.

Euromedis Groupe SA Daily Average True Range (ATR) ChartEuromedis Groupe SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Euromedis Groupe SA.

Euromedis Groupe SA Daily On-Balance Volume (OBV) ChartEuromedis Groupe SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Euromedis Groupe SA.

Euromedis Groupe SA Daily Money Flow Index (MFI) ChartEuromedis Groupe SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Euromedis Groupe SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Euromedis Groupe SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Euromedis Groupe SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.700
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Euromedis with someone you think should read this too:
  • Are you bullish or bearish on Euromedis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Euromedis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Euromedis Groupe SA

I send you an email if I find something interesting about Euromedis Groupe SA.


Comments

How you think about this?

Leave a comment

Stay informed about Euromedis Groupe SA.

Receive notifications about Euromedis Groupe SA in your mailbox!